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PERSPECTIVEMind the Gap: Sex Bias in Basic Skin Research
Betty Y. Kong1,2, Isabel M. Haugh1,2, Bethanee J. Schlosser1, Spiro Getsios1 and Amy S. Paller1Given the recent National Institutes of Health proposal for balanced use of male and female cells and animals
in preclinical studies, we explored whether sex bias exists in skin research. We surveyed 802 dermatological
research articles from 2012 through 2013. No information about the sex of studied cells or animals was provided
in 60% of papers. Among keratinocytes of known sex, 70% were male. Few studies compared male versus
female cells or animals. Disclosure of sex and comparative studies contribute to our understanding of the
biologic basis of sex differences. Addressing sex-specific differences in preclinical research informs subse-
quent clinical trial design and promotes individualized therapy.
Journal of Investigative Dermatology (2016) 136, 12e14; doi:10.1038/JID.2015.298More than 20 years ago, the US
National Institutes of Health estab-
lished the Office of Research on
Women’s Health, aimed in part at
increasing representation of women in
clinical trials. A parallel call to action,
however, for male and female sex rep-
resentation in cell- and animal-based
research was only raised in October
2014, when the National Institutes
of Health announced its intention
to develop guidelines requiring in-
vestigators to report plans for balancing
male and female cells and animals in
preclinical studies (Clayton and Collins,
2014; Sandberg et al., 2015).
More women than men seek derma-
tological consultation for skin disease;
our analysis of 149,614 patients seen
for cutaneous issues (based on ICD-9
diagnosis codes) in outpatient clinics
at Northwestern Medicine revealed a
female to male ratio of 1.8:1. Although
social behavior may influence seeking
consultation, biological differences may
underpin this imbalance. For example,
women exhibit a greater prevalence of
rosacea, lupus, and scleroderma with
a different distribution of androgenetic
alopecia in comparison with men. In
addition, melanoma incidence rates
are higher in younger females and
older males (Liu et al., 2013), with a
higher death rate from melanoma in
males (De Giorgi et al., 2011; Joosse
et al., 2011).1Department of Dermatology, Northwestern Universi
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to discover and elucidate differences
in disease prevalence, impact, and
response to interventions, which could
have a genetic, epigenetic, hormonal,
and/or behavioral (e.g., sun protection
habits) basis. Several results from
in vitro and in vivo comparative
research show that differences originate
from intrinsic cellular differences and
are further dichotomized by the
different hormonal environments to
which they are exposed. For example,
CD4þ T cells from women produce
more IFNg (Th1 bias) and from men
produce more IL-17A (Zhang et al.,
2012). Male gut microbiota transferred
to female nonobese diabetic mice pro-
tects against the development of
autoimmunity in an androgen receptor-
dependent manner (Markle et al.,
2013). These differences begin to
explain the predominance of autoim-
mune disorders in women.
In cutaneous biology, comparative
studies arebeginning todefine thedistinct
action of estrogen on estrogen alpha and
beta receptors and their relationships
with the IGF-1 receptor in understanding
wound re-epithelialization, macrophage
polarization, and why skin wound heal-
ing is slower in men than in women
(Campbell et al., 2010; Emmerson et al.,
2012, 2013; Markiewicz et al., 2013;
Campbell et al., 2014). The impact of
estrogen on keratinocyte differentiationty Feinberg School of Medicine, Chicago, Illinois, US
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(Brooks et al., 2014), as well as the
lower catalase levels in the skin and
ultraviolet B-induced myeloid cells of
male mice (Sullivan et al., 2012) may
contribute to the two- to threefold
increase in nonmelanoma skin cancers
in men and the larger, histologically
advanced, more numerous, and less
inflamed UVB-induced SCCs in male
hairless mice (Thomas-Ahner et al.,
2007). Finally, sex-specific differences
in the expression of glucocorticoid
receptors exist in the liver, central
nervous system, and immune system,
suggesting that male skin may also
be more sensitive to corticosteroids
(Chrousos, 2010; Duma et al., 2010;
Quinn et al., 2014).
To explore how often discovery in
cutaneous biology stems from the study
of one sex and whether sex is dis-
closed, we evaluated a cohort of
research publications from 1 January
2012 to 31 December 2013 that
included all “Original Articles” in three
dermatological science-focused jour-
nals (Journal of Investigative Derma-
tology, Journal of Dermatological
Science, and Experimental Derma-
tology). Of 802 original articles
reviewed, one or more animal model
or cell type was studied in 549
(Table 1). Both animals and cells were
studied in 143 papers, more than one
cell type in 126, and more than oneA
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Table 1. Published reports using cells and animals in skin research
Journal No sex stated Male only Female only Both sexes Total
Cells1 J Invest Dermatol 119 112 14 9 254
J Dermatol Sci 104 26 4 0 134
Exp Dermatol 100 34 4 9 147
Total 323 172 22 18 535
Mice2 J Invest Dermatol 124 11 44 5 184
J Dermatol Sci 21 12 19 3 55
Exp Dermatol 14 8 15 4 41
Total 159 31 78 12 280
1Cells included primarily normal human keratinocytes, melanocytes, and fibroblasts.
2Other animal models used included rat (N¼8), zebrafish (N¼5), rabbit (N¼4), pig (N¼2), guinea pig
(N¼2), horse (N¼1), hamster (N¼1), chicken (N¼1), and sheep (N¼1).
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one mouse strain).
Among 535 papers utilizing cultured
cells, 60.4% disclosed no information
about the sex of origin, whereas 32.1%
used only male cells and 4.1% only
female cells (Figure 1a). Only 3.3% of
studies examined male and female cells
but rarely in the same experiments. Of
139 studies utilizing normal human
keratinocytes (most common cell type),
sex was unstated in 60.4%, only male in
29.5%, only female in 4.3%, and both
sexes in 5.8% (Figure 1b). Forty-four
publications utilized the HaCaT kerati-
nocyte line, which originated from aFigure 1. Underreporting of cell and animal sex in b
publications with cells or mice. “Both sexes” largely
experiments, rather than comparative research. (b) Se
keratinocyte cell lines. HaCaT cells, a spontaneouslymale patient (Boukamp et al., 1988).
The preponderance of studies with male
cells is not surprising, given the easy
availability of male foreskins as a source
of cultured cells. However, our knowl-
edge from these male sex-biased studies
may not be generalizable if inherent cell
differences related to sex exist.
Animal models were studied in
305 papers, with mice used in 92.1%
(Table 1). Mouse sex was unspecified in
56.8% of the papers, but 27.9% re-
ported only females and 11.1% only
males (Figure 1a). This relatively greater
use of female mice may reflect the
greater aggressiveness of male mice.asic skin research. (a) N ¼ total number of
represents different sex used in different
x distribution in normal human keratinocytes and
transformed keratinocyte line, are of male origin.Mice of both sexes were used in 4.3%
of papers, but few compared male and
female mice in the same experiments.
Our findings of sex bias in basic
science skin research are echoed by
studies in other fields (Beery and
Zucker, 2011; Taylor et al., 2011; Yoon
et al., 2014), in which the sex of the
origin of cells and animals was largely
unreported and, if known, was primarily
male. Tissue from noncutaneous sour-
ces is no more accessible in males than
females; hence, this sex bias most likely
originates from the historical conven-
tion of using male-only models in
biomedical research. Concerns about
hormonal effects and added financial
costs to adequately power both male
and female cohorts, coupled with an
insufficient appreciation for potential
differences in outcome, may further
exacerbate the bias. Moreover, the age
of the source of cells (i.e., neonatal
versus adult) makes a difference bio-
logically (Gilchrest, 1983; Gilchrest
et al., 1982; Gilchrest et al., 1984).
Thus, testing hypotheses in both male
and female adult skin-derived cells not
only addresses sex bias but also more
closely models downstream clinical
applications. Male and female skin for
culture is currently available from
abdominoplasties, reduction mammo-
plasties, rhytidoplasties (face lifts), and
normal volunteers.
Why is it important to perform
comparative analyses? Limiting studies
to only one sex may lead to discoveries
that are only relevant for one sex.
Furthermore, having preclinical studies
in mice of a single sex increases the risk
of designing clinical trials that are
inappropriate or even harmful for the
non-studied sex. Of the 10 prescription
drugs withdrawn from the US market
between 1997 and 2000, eight “posed
greater health risks for women than
for men,” and half of these were
widely prescribed to both sexes (http://
www.gao.gov/products/GAO-01-286R).
Perhaps the most widely publicized
case of sex differences in medication
response is the use of zolpidem
(Ambien) for insomnia. More than
20 years after its initial approval, the
recommended dose for women was
decreased after new data revealed
slower medication metabolism among
females (Greenblatt et al., 2000). Atwww.jidonline.org 13
BY Kong et al.
Sex Bias in Basic Skin Research
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effects, which required withdrawal or
dosing modification, might have been
discovered preclinically if comparative
testing had been performed.
We consider further study of possible
differences in biologic responses of male
and female cells to be an important
unmet need. Testing of cells and tissues
in both sexes should be the norm. As a
reasonable first step, we suggest that
scholarly journals, and particularly
dermatological journals, require authors
to state the sex and age of animals and
cells of origin, and encourage re-
searchers to report observed sex- and
age-based differences. Further, we
recommend the increased commercial
availability and utilization of well-
characterized skin cells from varied
sources (male and female, young and
aging). Accounting for sex in research,
whether by regulatory agencies or in
grant applications, must be balanced
against the increased cost of replicating
studies in both sexes, particularly in
animal studies. Nevertheless, preclinical
research that considers sex- and age-
based influences could prevent the
later discovery of response differences in
expensive clinical trials, making the in-
cremental allocation of funding toward
this goal likely to be cost-effective.
Ultimately, addressing these questions
in preclinical research can improve
the clinician’s understanding of sex-
and age-based influences on normal
and pathological cellular responses and
inform the choice of intervention, further
individualizing therapy and preventing
adverse events.
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